We first described the recurrence of CD5, lambda, and kappa positive MALT lymphoma in the oral cavity and recurrent MALT lymphoma showed weak positivity for CD5 and kappa and negativity for lambda. This evidence concerns the gene CD5 and MALT lymphoma.